Growth inhibition induced by transforming growth factor-β1 in human oral squamous cell carcinoma

被引:32
|
作者
Wang, Xiumei [1 ,2 ]
Sun, Wenjing [1 ]
Bai, Jing [1 ,3 ]
Ma, Linlin [1 ]
Yu, Yang [1 ]
Geng, Jingshu
Qi, Jiping [4 ]
Shi, Zhongcheng [1 ]
Fu, Songbin [1 ,3 ]
机构
[1] Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China
[2] Harbin Med Coll, Affiliated Hosp 2, Harbin 150081, Peoples R China
[3] Biopharmaceut Key Lab Heilongjiang Prov, Harbin 150081, Peoples R China
[4] Harbin Med Coll, Affiliated Hosp 1, Harbin 150001, Peoples R China
关键词
TGF-beta; Smads; TGF-beta receptor; Signal transduction; Growth inhibition; Metastasis; BETA SIGNALING PATHWAY; TUMOR-SUPPRESSOR GENE; DOWN-REGULATION; RECEPTOR GENE; CANCER-CELLS; C-MYC; SMAD4; EXPRESSION; HEAD; NECK;
D O I
10.1007/s11033-008-9256-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral squamous cell carcinoma (OSCC) is a world-wide health problem and its incidence accounts for 1.9-3.5% of all malignant tumors. Transforming growth factor beta/Smads (TGF-beta/Smads) signaling pathway plays an important role in oncogenesis, but its function and molecular mechanisms in OSCC remain unclear. Expression of transforming growth factor-beta receptor type II (T beta RII) and Smad4 was studied by immunohistochemistry in 108 OSCC patients and 10 normal controls. Function and molecular mechanisms of TGF-beta/Smads signaling pathway was then investigated in two human tongue squamous carcinoma cell lines with high and low metastasis (Tb and Tca8113) by RT-PCR, Western Blot, immunofluorescence, cell growth curve and flow cytometry (FCM), respectively. T beta RII and Smad4 were significantly down-regulated in tumor tissues (with or without lymph node metastasis) compared to normal oral epithelium tissues (P < 0.05). TGF-beta 1 induced arrest of the cell cycle rather than cell death in Tca8113 and Tb cells, and this influence was mediated by the increasing the expression and changing the location of its downstream components of TGF-beta 1/Smads signaling pathway. TGF-beta 1 rapidly increased the expression of p15 and p21 in both Tca8113 and Tb cells. TGF-beta 1 did not increase p27 expression in Tca8113 cells, but p27 expression was increased in Tb cells. These indicated that TGF-beta 1 induced G(1) arrest of cell cycle through a different regulating pathway in Tb cells compared with Tca8113 cells. Thus, we conclude that TGF-beta/Smads signaling pathway play a important role on cell growth and metastasis potential in OSCC.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 50 条
  • [1] Growth inhibition induced by transforming growth factor-β1 in human oral squamous cell carcinoma
    Xiumei Wang
    Wenjing Sun
    Jing Bai
    Linlin Ma
    Yang Yu
    Jingshu Geng
    Jiping Qi
    Zhongcheng Shi
    Songbin Fu
    [J]. Molecular Biology Reports, 2009, 36 : 861 - 869
  • [2] LncRNA PAPAS promotes oral squamous cell carcinoma by upregulating transforming growth factor-β1
    Zhang, Panpan
    Liu, Ying
    Li, Chong
    Zhang, Li
    Liu, Qing
    Jiang, Tao
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (09) : 16120 - 16127
  • [3] Unravelling transforming growth factor-β signalling in human cutaneous squamous cell carcinoma
    Rose, A.
    Pourreyron, C.
    Purdie, K.
    Harwood, C.
    Leigh, I.
    Proby, C.
    South, A.
    Inman, G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 30 - 31
  • [4] Unravelling transforming growth factor-β signalling in human cutaneous squamous cell carcinoma
    Rose, A.
    Pourreyron, C.
    Purdie, K.
    Harwood, C.
    Leigh, I.
    Proby, C.
    South, A.
    Inman, G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : E42 - E43
  • [5] The paradoxical role of transforming growth factor-β in controlling oral squamous cell carcinoma development
    Peng, Ruiting
    Huang, Yun
    Huang, Ping
    Liu, Linyi
    Cheng, Lei
    Peng, Xian
    [J]. CANCER BIOMARKERS, 2024, 40 (3-4) : 241 - 250
  • [6] Transforming growth factor-β inhibitor is a candidate drug for immunotherapy of oral squamous cell carcinoma
    Kondo, Yutaro
    Takahara, Taishi
    Ono, Shoya
    Goto, Mitsuo
    Ogawa, Tetsuya
    Ito, Hideaki
    Sato, Akira
    Tsuzuki, Toyonori
    Yoshikawa, Kazuhiro
    Ueda, Ryuzo
    Suzuki, Susumu
    [J]. CANCER SCIENCE, 2022, 113
  • [7] Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma
    Kim, Seong-Gon
    Song, Ji-Young
    [J]. ONCOLOGY REPORTS, 2012, 28 (02) : 539 - 544
  • [8] Differential expression of transforming growth factor-β receptors in squamous cell carcinoma
    Kubo, M
    Ihn, H
    Yamane, K
    Asano, Y
    Jinnin, M
    Tamaki, K
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2001, 145 (05) : 840 - 842
  • [9] Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β
    F Vincent
    M Nagashima
    S Takenoshita
    M A Khan
    A Gemma
    K Hagiwara
    W P Bennett
    [J]. Oncogene, 1997, 15 : 117 - 122
  • [10] Inhibition of human neutrophil degranulation by transforming growth factor-β1
    Shen, L.
    Smith, J. M.
    Shen, Z.
    Eriksson, M.
    Sentman, C.
    Wira, C. R.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 149 (01): : 155 - 161